Talquetamab further investigated in heavily pre-treated MM after promising phase 2 data Presented ByProf. Ajai Chari, Mount Sinai School of Medicine, NY, USA TrialPhase 1/2, MonumenTAL-1 ConferenceASH 2022 20 February, 2023 12:19